Pancreatic Cancer Research

ResearcherHirosaki UniversityActive in the last 2 years

Yusuke Wakasa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9106-6002; OpenAlex author ID A5058441725. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 3 papers

Papers 4

  1. Neoadjuvant chemotherapy remodels the three-dimensional vascular architecture and immune microenvironment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.humpath.2026.106238↗
  2. Limited Survival Benefit of Short-Course Neoadjuvant Gemcitabine Plus Nab-Paclitaxel for Resectable Pancreatic Cancer: A Prospective Phase II Study With a Prop… Co-author DOI 10.1016/j.jss.2026.08.063↗
  3. Prognostic Utility of the Cachexia Index in Resectable and Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Chemotherapy. Co-author DOI 10.1097/mpa.0000000000002706↗
  4. [A Case of Remnant Pancreatic Cancer after Conversion Surgery for Advanced Distal Bile Duct Cancer Treated with Chemotherapy]. Co-author PMID 30692392↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenichi Hakamada · 4 shared papers, 2018–2026 · strength 1.01
  2. Keinosuke Ishido · 4 shared papers, 2018–2026 · strength 1.01
  3. Hayato Nagase · 3 shared papers, 2026 · strength 0.93
  4. Satoru Tsuruta · 3 shared papers, 2026 · strength 0.93
  5. Taiichi Wakiya · 1 shared paper, 2026 · strength 0.32
  6. Kenta Ogasawara · 1 shared paper, 2026 · strength 0.26
  7. Tadashi Yoshizawa · 1 shared paper, 2026 · strength 0.26
  8. Hiroshi Kijima · 1 shared paper, 2026 · strength 0.26
  9. Yoshiki Nishiyama · 1 shared paper, 2026 · strength 0.26
  10. Shintaro Goto · 1 shared paper, 2026 · strength 0.26
  11. Shingo Sakuraba · 1 shared paper, 2018 · strength 0.09
  12. Daisuke Kudo · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.